U.S. indicts Indivior over Suboxone opioid treatment marketing

The U.S. Justice Department on Tuesday announced the indictment of Indivior Plc on charges it engaged in an illegal scheme to increase prescriptions of its opioid addiction treatment Suboxone to make billions of dollars.